CO

CONTX.OL

$4.21
Sharia status
COMPLIANT
Per In-house ratio engine · assessed 2026-09-08
HTR non-permissible income 0.93%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

ContextVision AB (publ) (CONTX.OL) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-09-08). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Institutional own.
6.9%
of shares
COMPLIANT
Sharia compliance
0.93%
Non-permissible income — HTR, from filings (2025-12-31)
6.9%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. CONTX.OL files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass

RatioValueThresholdResult
Interest-bearing debt 4.03% 30.00% Pass
Interest-bearing investments 22.35% 30.00% Pass
Non-permissible income 0.93% 5.00% Pass

Usmani Fail

RatioValueThresholdResult
Interest-bearing debt 10.08% 33.00% Pass
Interest-bearing investments 55.92% 33.00% Fail
Non-liquid assets 28.18% at least 20.00% Pass
Non-permissible income 0.93% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 10.08% 33.33% Pass
Cash + interest-bearing securities 55.92% 33.33% Fail
Accounts receivable 71.82% 33.33% Fail
Non-permissible income 0.93% 5.00% Pass

FTSE Fail

RatioValueThresholdResult
Interest-bearing debt 10.08% 33.33% Pass
Cash + interest-bearing securities 55.92% 33.33% Fail
Accounts receivable 71.82% 50.00% Fail
Non-permissible income 0.93% 5.00% Pass

Dow Jones Islamic Market Pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.79% 33.00% Pass
Cash + interest-bearing securities 21.03% 33.00% Pass
Accounts receivable 5.98% 33.00% Pass
Non-permissible income 0.93% 5.00% Pass

S&P Shariah Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.22% 33.00% Pass
Cash + interest-bearing securities 17.86% 49.00% Pass
Accounts receivable 5.08% 49.00% Pass
Non-permissible income 0.93% 5.00% Pass

MSCI M-Series Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.22% 33.33% Pass
Cash + interest-bearing securities 17.86% 33.33% Pass
Accounts receivable 22.94% 49.00% Pass
Non-permissible income 0.93% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

4.844.343.843.342.842025-09-112026-03-112026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
3.73
S2
3.87
S1
4.00
PIVOT
4.14
R1
4.27
R2
4.41
R3
4.54

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
3.52282 4.71718
±14.49% from 4.12, made 2026-09-09 · resolves 2026-09-16
STRONG BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 21865 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 4 neutral · 0 sell
Moving averagesSTRONG BUY
12 buy · 0 neutral · 0 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)65.80NEUTRAL
Stochastic %K (14)74.11NEUTRAL
CCI (20)71.55NEUTRAL
Williams %R (14)-25.89NEUTRAL
MACD (12,26,9)0.03BUY
ROC (10)18.59BUY
Momentum (10)0.66BUY
EMA (10)4.10BUY
SMA (10)4.19BUY
EMA (20)3.93BUY
SMA (20)3.84BUY
EMA (30)3.81BUY
SMA (30)3.71BUY
EMA (50)3.69BUY
SMA (50)3.57BUY
EMA (100)3.61BUY
SMA (100)3.54BUY
EMA (200)3.71BUY
SMA (200)3.57BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About ContextVision AB (publ)

Healthcare · Health Information Services

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women's health, veterinary medicine, and point of-care applications. It also provides Altumira platform, which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, the company offers image quality solutions for MRI including GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; and implementation projects, software updates, and upgrades and product support services. It has a strategic clinical development partnership with the University of Washington to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD; and research partnership with AMRA Medical. ContextVision AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden.

contextvision.se ↗

Background via Yahoo Finance — informational, not part of the verdict.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.